TEACHER PROGRAM: SEMINAR SERIES

Whitehead Institute’s 2015-2016 Seminar Series for High School Teachers: Precision Medicine

Historically, physicians have practiced medicine with a “one size fits all” approach. As a result, even our most skilled clinicians and scientists lack a complete understanding of how and why people often respond differently—or not at all—to the same treatment regimens.

Today, however, that approach is changing dramatically. A new vision of personalized, or precision, medicine is emerging. Advances in drug discovery, approvals of targeted therapies, and development of novel diagnostic technologies are bringing us closer to an era of customized disease treatment and prevention.

Whitehead Institute’s 2015-2016 Lecture Series for High School Teachers, Precision Medicine, examined how these new technological breakthroughs are accelerating the field of precision medicine and transforming the framework of everyday clinical practice.


KICK-OFF SESSION: MONDAY, OCTOBER 5, 2015

PRECISION CONTROL OF PROTEIN FOLDING TO TREAT CANCER AND NEURODEGENERATIVE DISEASES

David Pincus, Fellow, Whitehead Institute
[presentation pdf, 7.4MB]


MONDAY, NOVEMBER 2, 2015

METABOLOMICS AND LIPIDOMICS: NEW DIMENSIONS IN UNDERSTANDING HEALTH AND DISEASE

Lisa Freinkman, Research Scientist and Manager, Metabolite Profiling Facility, Whitehead Institute
[presentation pdf, 2.9MB]


MONDAY, DECEMBER 7, 2015

USING CANCER GENOMICS TO GUIDE TREATMENT DECISIONS IN CANCER

Eliezer Van Allen, Instructor in Medicine, Harvard Medical School, Department of Oncology at Dana-Farber Cancer Institute and Research Associate, Broad Institute
[In lieu of his lecture slides, Dr. Van Allen has provided this recorded lecture]


MONDAY, JANUARY 11, 2016*

MULTISCALE GENOME ENGINEERING: GENOME-WIDE SCREENS AND TARGETED APPROACHES

Neville Sanjana, Simons Postdoctoral Fellow, Zhang Lab, Broad Institute & MIT; Core Faculty Member, New York Genome Center (beginning April 2016)
presentation not available 


MONDAY, FEBRUARY 1, 2016

CANCER THERAPIES

Richard Young, Member, Whitehead Institute
presentation not available 


MONDAY, MARCH 7, 2016

HOW NEXT-GENERATION SEQUENCING MAY LEAD TO MORE PERSONALIZED, TARGETED THERAPIES FOR CANCER AND OTHER DISEASES

Dr. Wendy Winckler, Executive Director, Next Generation Diagnostics, Novartis Institutes for Biomedical Research
presentation not available 


MONDAY, APRIL 4, 2016

3D CULTURE OF PATIENT DERIVED MAMMARY TISSUE: IMPLICATIONS FOR PERSONALIZED MEDICINE

Ethan Sokol, Graduate Student, Gupta Lab, Whitehead Institute
[presentation pdf, 4.8MB


MONDAY, MAY 2, 2016

SYSTEMATIC APPROACHES TO IDENTIFY THE VULNERABILITIES OF CANCER

Tanaz Sharifnia, Postdoctoral Fellow in the lab of  Stuart Schreiber at Broad Institute
presentation not available  


MONDAY, JUNE 6, 2016

RANA'S APPROACH TO TREATING DISEASES BY TARGETING LNCRNAS

Caroline J Woo, Senior Scientist, RaNA Therapeutics
presentation not available  

 

*Please note the change of date.

Slide of neurons

These neurons arose from induced pluripotent stem cells (iPSCs) that were made from the cells of a patient with Parkinson's diease. A green-stained protein highlights the neurons' structures.  DNA in the neuron's nuclei is stained blue.

© Whitehead Institute for Biomedical Research              455 Main Street          Cambridge, MA 02142